| 2019-07 |
Cathepsin S inhibition alleviates oxaliplatin-induced peripheral neuropathy through regulation of Ca2+homeostasis |
Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 2942. |
|
| 2018-12 |
The clinical implication of O6 methylguanine DNA methyltransferase in rectal cancers |
Cancer Science. 2018 Dec;109(Suppl. 2):1369. |
 |
| 2018-01 |
O6BG modulates the repair activity of homologous recombination and its clinical application |
Cancer Science. 2018 Jan;109(Suppl. 1):379. |
|
| 2016-02 |
Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors |
Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 745. |
|
| 2015-08 |
MPT0B292 enhances acetylation of alpha-tubulin through up-regulation of acetyltransferase gene, MEC-17 and exhibits potent anti-tumor, anti-angiogenesis and anti-metastatic effects in vitro and in vivo |
Cancer Research. 2015 Aug;75(Suppl. 15):Abstract number 4379. |
|
| 2015-05 |
Enhanced antitumor activity of rapamycin and genipin, a UCP-2 inhibitor, in lung cancer |
Journal of Clinical Oncology. 2015 May;33(15, Suppl.):e13595. |
|
| 2015-04 |
The role of miR-450a in oral squamous cell carcinoma carcinogenesis |
FASEB Journal. 2015 Apr;29(1, Suppl.):Abstract number 711.22. |
|
| 2014-11 |
CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors |
European Journal of Cancer. 2014 Nov;50(Suppl. 6):19-20. |
|
| 2014-10 |
Genetic polymorphisms of genes on the retinoic acid pathway and risk of head and neck cancer |
Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 4145. |
|
| 2014-10 |
Copper-chelator exerts synergistic interaction with platinum drugs through modulating copper transporters in oxaliplatin-resistant human gastric cancer cell |
Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 3753. |
|
| 2014-10 |
Identification of oral carcinoma miRNA signature and control OSCC tumorigenesis through Wnt/beta-catenin signaling |
Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 1487. |
|
| 2014-06 |
Reconstruction of exposed cohort and cumulative dose of radio-contaminated building residents for epidemiological study - Updated information |
Occupational and Environmental Medicine. 2014 Jun;71(Suppl. 1):A69. |
|
| 2014-05 |
High expression of Hsp90-beta and GRP 94 association with poor survival in resected non-small cell lung cancer patients |
Journal of Clinical Oncology. 2014 May;32(15, Suppl.):e13522. |
|
| 2013-06 |
Oral hygiene and risk of head and neck cancer |
American Journal of Epidemiology. 2013 Jun;177(Suppl. 11):S58. |
|
| 2013-04 |
Functional implication of TGFBR3 dysregulation and its clinical application in oral cancer |
Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 3987. |
|
| 2013-04 |
Generation and characterization of highly selective cathepsin S inhibitors with potentials against pancreatic cancer |
Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 5562. |
|
| 2013-04 |
EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients |
Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 2390. |
|
| 2013-04 |
Autophagy induced by cathepsin S inhibition causes early ROS production for oxidative DNA damage and subsequent cell death |
Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 1661. |
|
| 2012-11 |
Overexpression of Discoidin Domain Receptor 1 (DDR1) in oral squamous cell carcinoma |
European Journal of Cancer. 2012 Nov;48(Suppl. 6):167. |
|
| 2012-11 |
Blockage of Nrf2/AKR1C axis enhanced therapeutic efficacy of oxaliplatin in oxaliplatin resistant gastric cancer cells |
European Journal of Cancer. 2012 Nov;48(Suppl. 6):48. |
|
| 2012-11 |
MicroRNA-99a, a tumor suppressor in oral squamous cell carcinoma regulates insulin-like growth factors I receptor in a double-negative feedback loop |
European Journal of Cancer. 2012 Nov;48(Suppl. 6):120. |
|
| 2012-04 |
DNA polymerase eta and a novel anticancer selenophene compound |
Cancer Research. 2012 Apr;72:Abstract number 3813. |
|
| 2012-02 |
Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on firstline oxaliplatin-based chemotherapy |
Journal of Clinical Oncology. 2012 Feb;30(4):613. |
|
| 2011-09-23 |
BPR1K653, a novel Aurora Kinase Inhibitor, exhibits potent anti-proliferative activity in P-gp170 (MDR1)-mediated VX680-resistant cancer cells in vitro and in vivo |
European Journal of Cancer. 2011 Sep 23;47:S127. |
|
| 2011-09-23 |
A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou |
European Journal of Cancer. 2011 Sep 23;47:S547-S548. |
|
| 2011-09 |
DNA repair enzyme, O6-methylguanine DNa methyltransferase, modulates therapeutic efficacy of platinum drugs with radiation and its clinical significance |
European Journal of Cancer. 2011 Sep;47:S132. |
|
| 2011-07 |
MicroRNA signature and aberrant methylation in human oral squamous cell carcinomas |
Oral Oncology. 2011 Jul;47(Suppl. 1):S92. |
|
| 2011-05 |
Pharmacokinetic study with novel anticanacer agents, MPTOB124 and MPTOB214 |
Drug Metabolism Reviews. 2011 May;43(Suppl. 1):73. |
|
| 2011-04 |
Activation of Akt/FoxO axis confers resistance to cisplatin in human nasopharyngeal carcinomas |
Cancer Research. 2011 Apr;71:Abstract number 1701. |
|
| 2011-04 |
Activation of NRF2/ABCC1 axis confers resistance to topoisomerase II poisons in human oral malignancies |
Cancer Research. 2011 Apr;71:Abstract number 1528. |
|
| 2011-04 |
MPT0B098, a novel microtubule inhibitor, displays potent anti-angiogenic activity via destabilizing hypoxia-inducible factor-1alpha mRNA |
Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 4461. |
|
| 2011-04 |
Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway |
Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 2864. |
|
| 2010-10 |
Combined modalities of resistance in a cisplatin-driven human betel-associated oral squamous cell carcinoma |
Annals of Oncology. 2010 Oct;21(Suppl. 8):52. |
|
| 2010-06 |
Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma |
Annals of Oncology. 2010 Jun;21(Suppl. 6):27. |
|
| 2009-09 |
Synergistic augmentation of arsenic trioxide-induced cytotoxicity by BCNU through reactive oxygen species-related autophagic pathway in human solid tumors |
EJC Supplements. 2009 Sep;7(3):16. |
|
| 2009-05-20 |
Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC) |
Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number 4587. |
|
| 2009-05 |
Down-regulation of survivin enhances sensitivity to BPROL075 in human cancer cells via caspase-independent mechanisms |
Cancer Research. 2009 May;69:Abstract number 5542. |
|
| 2007-07 |
A novel oral indoline-sulfonamide derivative, J30, exhibits potent activity against human cancer cells both in in vitro and in vivo through disruption of microtubule |
Drugs of the Future. 2007 Jul;32(Suppl. A):35-36. |
|
| 2006-11 |
Combined modalities of resistance in an oxaliplaitin-resistant human gastric cancer cell line with enhanced sensitivity |
EJC Supplements. 2006 Nov;4(12):59. |
|
| 2006-11 |
D-501036, a novel selenophene-base triheterocycle derivative exhibits potent in vitro and in vivo anti-tumoral activity, which involves DNA-damage and ATM activation |
EJC Supplements. 2006 Nov;4(12):92. |
|
| 2006-11 |
Tamoxifen induces degradation of the o6-methylguanine DNA methyltransferase protein via the ubiquitin-dependent proteosome pathway in human cancer cells |
EJC Supplements. 2006 Nov;4(12):155. |
|
| 2006-02 |
DNA repair enzyme, O-6-methylguanine DNA methyltransferase, modulates cytotoxicity of camptothecin-derived topoisomerase I inhibitors |
Journal of Pharmacology and Experimental Therapeutics. 2006 Feb;316(2):946-954. |
|
| 2006-01 |
Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma |
Head and Neck. 2006 Jan;28(1):74-80. |
|
| 2005-12 |
Induction of cell death by a novel selenophene derivative, D-501036, in human cancer cell lines |
Clinical Cancer Research. 2005 Dec;11(24):9101S. |
|
| 2004-09 |
Drug design of BPR0L075 as an anticancer agent |
World Conference on Magic Bullets - Celebrating Paul Ehrlich's 150th Birthday. 2004 Sep 9-11:Abstract # 203. |
|
| 2004-08-02 |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer |
British Journal of Cancer. 2004 Aug;91(3):453-458. |
|
| 2004-07 |
Drug design for BPR0L075 as an anticancer agent |
Medicine in the 21st Century Tri-Conference & Bio-Forum 2004 Shanghai International Convention Center. 2004 Jul. |
|
| 2002 |
Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma |
International Journal of Cancer. 2002;Suppl. 13:336-337. |
|
